Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03354559
Other study ID # 14752/15
Secondary ID
Status Completed
Phase N/A
First received November 8, 2017
Last updated November 24, 2017
Start date January 1, 2011
Est. completion date December 31, 2014

Study information

Verified date November 2017
Source Policlinico Universitario Agostino Gemelli
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In severe trauma patients, uncontrolled bleeding is a major cause of death, partly caused by trauma-induced coagulopathy (TIC).TIC represents a severe post-traumatic complication associated with increased transfusion requirements and worsened mortality. Fibrinolysis is a central part of the TIC process. Massive Transfusion Protocols (MTPs) were introduced as part of damage control resuscitation, with the aim to facilitate rapid blood product release and to increase adherence to hemostatic resuscitation, In 2013, the Italian Trauma Centers Network (TUN) developed a new treatment algorithm providing early coagulation support (ECS) to control coagulopathy and hemorrhage in major trauma patients with a clinically relevant bleeding risk. The protocol includes the use of fibrinogen concentrate and RBC during initial resuscitation, and the early use of viscoelastic techniques when available (thromboelastometry ROTEM® or thromboelastography TEG).

The aim of this multicenter, before and after study was to assess the effects of a new ECS protocol compared to the standard MTP in terms of blood products' consumption and clinical outcome.


Description:

In severe trauma patients, uncontrolled bleeding is a major cause of death, partly caused by trauma-induced coagulopathy (TIC).TIC represents a severe post-traumatic complication associated with increased transfusion requirements and worsened mortality. Fibrinolysis is a central part of the TIC process. Damage control resuscitation is defined as rapid hemorrhage control through early administration of blood products prevention and immediate correction of coagulopathy, and minimization of crystalloid fluids. Massive Transfusion Protocols (MTPs) were introduced as part of damage control resuscitation, with the aim to facilitate rapid blood product release and to increase adherence to hemostatic resuscitation, following a transfusion ratio of 1:1:1 of fresh frozen plasma (FFP), platelets (PLT) and packed red blood cells (pRBC). Their activation is triggered by clinical parameters, including patients' trauma severity, clinical signs and laboratory data, which are included in scoring systems. In 2013, the Italian Trauma Centers Network (TUN) developed a new treatment algorithm providing early coagulation support (ECS) to control coagulopathy and hemorrhage in major trauma patients with a clinically relevant bleeding risk. The protocol includes the use of fibrinogen concentrate and RBC during initial resuscitation, and the early use of viscoelastic techniques when available (thromboelastometry ROTEM® or thromboelastography TEG).

The aim of this multicenter, before and after study was to assess the effects of a new ECS protocol compared to the standard MTP in terms of blood products' consumption and clinical outcome.

We undertook a before and after study using historical controls. We included all consecutive adult patients with major trauma at risk of bleeding admitted to the emergency department of two referral Trauma Centres in Rome, Italy (i.e. Fondazione Policlinico Universitario A. Gemelli and S. Camillo Hospital). Patients treated in 2011-2012 were compared to patients treated in 2013-2014. In the second period, the ECS protocol was concomitantly implemented as standard of care in both trauma centers. Informed consent was waived as all the procedures were considered the standard of care in both periods.

During the control period (pre-ECS), patients were treated according to a MTP with the following targets: FFP/PRBC ratio ≥ 1:1.5, target platelet count > 100.000 x 109/L. According to the ECS protocol applied in the study period, all included patients received an "initial resuscitation" ,defined as the period between hospital admission and the first available coagulation results (coagulation screen, fibrinogen level and/or viscoelastic monitoring and platelet count), with a fixed initial coagulation support of tranexamic acid (TA) 1 g intravenous bolus over 20 min followed by 1 g in continuous infusion over 8 hours and fibrinogen concentrate (FC) 2 g bolus along with 2 to 4 units of PRBCs. Point of care (POC) tests were systematically used to monitor coagulation and to guide subsequent interventions. FFP was not administered in the early treatment stage. Permissive hypotension (systolic arterial pressure 80-90 mmHg or mean arterial 50-60 mmHg) and a fluid restrictive strategy were applied until surgical bleeding control was achieved. However, when prolonged bleeding occurred and an increasing number of PRBCs (>4 units) and fluid volume was required (>2000 ml), plasma was transfused for hemodynamic and hemostatic resuscitation.

Data from the electronic records were matched with the blood bank registries to confirm the number of blood units transfused within the study's time span. For patients transferred from other hospitals, information regarding transfusions administered before admission were collected and matched with the blood banks' data.

Patients' characteristics at admission are summarized through mean and standard deviation for continuous variables. Median and interquartile range for scales and scores and relative frequencies are used for discrete variables. We tested the null hypothesis of no association between study period and patients' characteristics with the t-test, Wilcoxon test and chi-square test for the three types of variables, respectively. We estimated the mean difference in transfused units and length of stay between ECS and pre-ECS from unadjusted Poisson models, using the delta methods to estimate the 95% confidence interval (CI) for the mean difference. Findings were robust by replacing the Poisson model with a negative binomial distribution. In addition, we defined "multiple transfused patients" as those experiencing four or more RBC units during the first 24 hours. The cut-off of four PRBC units represented the sample 75th percentile.

We investigated the association between clinical features and the probability of multiple transfusion by means of univariate and multivariate logistic regression models. For the mortality outcome, we estimated the Relative Risk (RR) and its' 95% CI of death within the first 24 hours and within 28 days since admission for the post-ECS as compared to pre-ECS patients from Poisson models without adjustment for other variables. Among those surviving the first 24 hours, we replicated the analysis by considering death between the 2nd and the 28th day of hospital stay. Furthermore, we investigated whether differences in resources' use and mortality between ECS and pre-ECS were related to major patients' demographic and clinical features at presentation, including age (18-40, 40-65, 65+ years), severity of traumatic brain injury (head AIS <4 vs. ≥ 4), and trauma severity (number of critical illness criteria; presence/absence of each criterion). These stratified analyses were performed including a study period patients' feature interaction in separated Poisson models and by formally testing the null hypothesis of equal efficacy of the ECS protocol among categories of patients through an F test. To further control for any residual difference in clinical features between pre and ECS groups, we compared the resource consumption, the probability of multiple transfusion and the mortality outcomes among propensity-score matched patients. The propensity score included the following variables: age, sex, ISS, AIS head, worse SBP, base excess, lactates, hemoglobin and platelets. For the statistical analyses, we used the SAS software, 9.4 release (SAS Institute Inc., Cary, NC, US). The propensity score matching was performed using a standard macro.


Recruitment information / eligibility

Status Completed
Enrollment 235
Est. completion date December 31, 2014
Est. primary completion date December 31, 2014
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients with major trauma with active bleeding or deemed at high risk of significant bleeding according to mechanism of injury;

- patient with at least one of the following criteria were present on admission: lactate = 5 mmol/L, BE = - 6, or Hb = 9g/dL on the blood gas analysis and SBP<90 mmHg

Exclusion Criteria:

- Patients with cardiac arrest following trauma

- patients who died en route

- patients who were transferred more than six hours after the trauma

- patients or with incomplete medical reports

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Policlinico Universitario Agostino Gemelli San Camillo Hospital, Rome

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction of transfused units Amounts of transfused red blood cells, fresh frozen plasma and platelets between the two groups 24 hours
Secondary clinical outcome: the effects of the ECS protocol on length of stay Describe the effects on hospital stay and ICU stay, limited to the survivors beyond the first 24 hours, between the two groups (pre-ECS and ECS) 6 months
Secondary clinical outcome: the effects of the ECS protocol on mortality Evaluate any differences in mortality within the first 24 hours and within 28 days since admission between the two groups (pre-ECS and ECS period). 24 hours-28 days
See also
  Status Clinical Trial Phase
Recruiting NCT02509390 - Hyperfibrinogenemia After Major Trauma N/A
Recruiting NCT04970433 - The Effects of Acupuncture for Major Trauma N/A
Recruiting NCT04588311 - ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients Phase 3
Active, not recruiting NCT04144803 - Brain Oxygenation During Prehospital Anesthesia: an Observational Study
Completed NCT03259776 - Experiences of Visitors to a Regional Major Trauma Intensive Care Unit
Recruiting NCT05449522 - Vitamin D for Critically Traumatic Patients N/A
Not yet recruiting NCT06103292 - Calcium Levels in Major Trauma
Recruiting NCT02877342 - Pre-hospital Notification of Injured Patients Presenting to Trauma Centres in India N/A
Terminated NCT01545635 - RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma Phase 3
Completed NCT03986736 - Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma
Completed NCT03005509 - Structured Trauma Quality Improvement Meetings at Four Trauma Centres in India N/A
Completed NCT02165137 - Management of Major Trauma Patients at Aarau Trauma Center - Evaluation of Processes and Patient Outcome
Active, not recruiting NCT06376318 - Shock and Acute Conditions OutcOmes Platform
Recruiting NCT05996068 - Arterial Line in Trauma Resuscitation N/A
Completed NCT06007807 - Severe Trauma Registry in Tarragona
Recruiting NCT05652790 - Enhanced Rehabilitation After Major Trauma (PROPERLY) N/A
Completed NCT00588796 - Study of Fibrinogen Metabolism During Severe Trauma and Burns N/A
Completed NCT04216459 - Effect of Anti-inflammatory and Anti-microbial Co-supplementations in Traumatic ICU Patients at High Risk of Sepsis N/A
Terminated NCT04551157 - Impact of Psychoeducational Video on Adjustment to Open Fracture. N/A
Completed NCT02000674 - Succinylcholine vs Rocuronium for Prehospital Emergency Intubation Phase 3